Complementary and alternative medicine (CAM) use by patients enrolled in phase I clinical trials.

被引:0
|
作者
Mandrekar, S [1 ]
Dy, GK [1 ]
Furth, A [1 ]
Bekele, L [1 ]
Hanson, L [1 ]
Sloan, J [1 ]
Adjei, AA [1 ]
机构
[1] Mayo Clin, Coll Med, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
8053
引用
收藏
页码:742S / 742S
页数:1
相关论文
共 50 条
  • [41] Prevalence of complementary and alternative medicine (CAM) use in Brazil
    Patricia de Moraes Mello Boccolini
    Cristiano Siqueira Boccolini
    BMC Complementary Medicine and Therapies, 20
  • [42] Physician use of complementary and alternative medicine (CAM) literature
    Wong, HCG
    Neill, JC
    COMPLEMENTARY THERAPIES IN MEDICINE, 2001, 9 (03) : 173 - 177
  • [43] Prevalence of complementary and alternative medicine (CAM) use in Brazil
    Mello Boccolini, Patricia de Moraes
    Boccolini, Cristiano Siqueira
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 20 (01) : 51
  • [44] Complementary and Alternative Medicine (CAM) use in Children with Epilepsy
    Zhu, Zahra
    Mittal, Rea
    Walser, Sarah A.
    Lehman, Erik
    Kumar, Ashutosh
    Paudel, Sita
    Mainali, Gayatra
    JOURNAL OF CHILD NEUROLOGY, 2022, 37 (05) : 334 - 339
  • [45] Complementary and Alternative Medicine (CAM)
    Moquin, Barbara
    Blackman, Marc R.
    Mitty, Ethel
    Flores, Sandi
    GERIATRIC NURSING, 2009, 30 (03) : 196 - 203
  • [46] Monitoring in clinical trials of complementary and alternative medicine
    Jung, So-Young
    Kang, Jung Won
    Kim, Tae-Hun
    INTEGRATIVE MEDICINE RESEARCH, 2021, 10 (02)
  • [47] Complementary or alternative? Patterns of complementary and alternative medicine (CAM) use among Finnish children
    Siponen, Sanna M.
    Ahonen, Riitta S.
    Kettis, Asa
    Hameen-Anttila, Katri P.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (12) : 1639 - 1645
  • [48] Complementary or alternative? Patterns of complementary and alternative medicine (CAM) use among Finnish children
    Sanna M. Siponen
    Riitta S. Ahonen
    Åsa Kettis
    Katri P. Hämeen-Anttila
    European Journal of Clinical Pharmacology, 2012, 68 : 1639 - 1645
  • [49] Biomarker selection for patients participating in phase I clinical trials.
    Eberst, Lauriane
    Basse, Clemence
    Morelle, Magali
    Simmet, Victor
    Terret, Catherine
    Pissaloux, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Potentially Dangerous Complementary and Alternative Medicine (CAM) Use by Ovarian Cancer Patients
    Andersen, M. Robyn
    Sweet, Erin
    Lowe, Kimberly A.
    Standish, Leanna J.
    Drescher, Charles W.
    Goff, Barbara A.
    JOURNAL OF GYNECOLOGIC SURGERY, 2012, 28 (02) : 116 - 120